<DOC>
	<DOC>NCT00842972</DOC>
	<brief_summary>This study was conducted to evaluate the effect of A1C variability on the progression of carotid artery intima-media thickness in type 2 diabetic patients.</brief_summary>
	<brief_title>Is Carotid Intima-media Thickness Affected by A1C Variability?</brief_title>
	<detailed_description />
	<criteria>type II fluoroscopy in carotid once a year during 2 years type 1 diabetes history or clinical evidence of coronary artery disease or cerebral or peripheral vascular disease the presence of albuminuria (defined as 24 hour urine albumin excretion ≥ 30 mg) renal dysfunction (defined as creatinine blood level ≥ 2.0 mg/dL) hepatic dysfunction (defined as alanine aminotransferase and/or aspartate aminotransferase blood level ≥ 3 × upper normal limit) smoking within the past 3 months prior to commencement of the study use of any medication likely to alter IMT such as calcium channel blocker, thiazolidinedione, antiplatelet agent (clopidogrel, cilostazol) use of glucocorticoid pregnancy severe concomitant disease such as cancer infection Cushing's syndrome acromegaly, or any other disorder likely to alter glycemia primary hypercholesterolemia hypothyroidism or hyperthyroidism use of any hormonal drugs alcoholism or drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>34 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>